Yield10 Bioscience Long Term Debt

Yield10 Bioscience (YTEN) currently reports a long-term debt of $1.1M as of June 2024. That compares with $2.8M in the prior-year period — down 61.4% year over year. Use the charts on this page to explore Yield10 Bioscience's long-term debt history and peer comparisons.

Yield10 Bioscience's long-term debt decreased from $2.8M to $1.1M — a 61.4% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Yield10 Bioscience reported $1.1M in long-term debt as of June 2024. That compares with $2.8M in the prior-year period — down 61.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Yield10 Bioscience, and consider following YTEN for alerts when major investors trade the stock.

Yield10 Bioscience is classified in the Consumer Discretionary sector. On long-term debt, it currently shows $1.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing YTEN with unrelated industries.